A randomized, double-blind, placebo-controlled clinical trial on once-daily atomoxetine hydrochloride in Taiwanese children and adolescents with attention-deficit/hyperactivity disorder

SUSAN SHUR-FEN GAUHuang Y.-S.Soong W.-T.Chou M.-C.Chou W.-J.CHI-YUNG SHANGTseng, Wan-LingWan-LingTsengAllen A.J.Lee P.2022-09-022022-09-02200710445463https://www.scopus.com/inward/record.uri?eid=2-s2.0-34548666657&doi=10.1089%2fcap.2006.0091&partnerID=40&md5=139548cf80ccddd82542931f3e67f107https://scholars.lib.ntu.edu.tw/handle/123456789/617746A randomized, double-blind, placebo-controlled clinical trial on once-daily atomoxetine hydrochloride in Taiwanese children and adolescents with attention-deficit/hyperactivity disorderjournal article10.1089/cap.2006.0091178223402-s2.0-34548666657